Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,290 | -20,990 | -19,370 | -5,050 | -23,090 |
| Depreciation Amortization | 4,200 | 450 | 800 | 790 | 1,750 |
| Other Working Capital | -40 | 400 | 710 | -660 | -1,460 |
| Other Operating Activity | 1,860 | 3,680 | 380 | 860 | 7,400 |
| Operating Cash Flow | $-17,270 | $-16,460 | $-17,480 | $-4,060 | $-15,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -270 | 210 | -320 | 680 | -680 |
| Other Investing Activity | -14,560 | 1,500 | 9,830 | -2,810 | 19,390 |
| Investing Cash Flow | $-14,830 | $1,710 | $9,510 | $-2,130 | $18,710 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -500 | -500 | -500 | -500 | -500 |
| Other Financing Activity | 73,230 | 2,510 | 9,550 | 15,300 | -330 |
| Financing Cash Flow | $72,730 | $2,010 | $9,050 | $14,800 | $-830 |
| Beginning Cash Position | 3,520 | 16,250 | 15,160 | 6,560 | 4,090 |
| End Cash Position | 44,140 | 3,520 | 16,250 | 15,160 | 6,560 |
| Net Cash Flow | $40,620 | $-12,730 | $1,080 | $8,600 | $2,460 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,270 | -16,460 | -17,480 | -4,060 | -15,400 |
| Free Cash Flow | -17,270 | -16,460 | -17,480 | -4,060 | -15,400 |